XML 43 R35.htm IDEA: XBRL DOCUMENT v2.4.0.8
ValveXchange (Details) (USD $)
1 Months Ended 9 Months Ended 3 Months Ended 1 Months Ended
Sep. 30, 2014
Dec. 31, 2013
Sep. 30, 2014
Long-Term Notes Receivable [Member]
Dec. 31, 2013
Long-Term Notes Receivable [Member]
Jul. 31, 2011
ValveXchange, Inc. [Member]
Sep. 30, 2014
ValveXchange, Inc. [Member]
Dec. 31, 2012
ValveXchange, Inc. [Member]
Dec. 31, 2013
Series A Preferred Stock [Member]
ValveXchange, Inc. [Member]
Sep. 30, 2014
Series A Preferred Stock [Member]
ValveXchange, Inc. [Member]
Jul. 31, 2011
Series A Preferred Stock [Member]
ValveXchange, Inc. [Member]
Apr. 30, 2014
Series B Preferred Stock [Member]
ValveXchange, Inc. [Member]
Sep. 30, 2014
Series B Preferred Stock [Member]
ValveXchange, Inc. [Member]
Schedule of Cost-method Investments [Line Items]                        
Preferred stock purchased, value                   $ 3,500,000    
Preferred stock, written down investment               3,200,000        
Preferred stock carrying value               0 0      
Loans receivable, revolving credit line, maximum capacity         2,000,000              
Loans receivable, revolving credit line, expiration date           Jul. 30, 2018            
Loans receivable, revolving credit line, interest rate         8.00%              
Loan origination costs net of fees         117,000              
Amount of loan advanced 2,000,000 2,000,000 2,000,000 2,000,000     2,000,000          
Percentage of any amounts in excess of agreed upon amount from fundraising to be paid to Cryolife                     10.00%  
Minimum amount raised before 10% of amounts raised in excess are paid to Cryolife                     1,250,000  
Amount raised                       $ 1,700,000